Vimarsana
Biggest News Aggregation in the World

Page 7 - Global Head News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Global Head. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Global Head Today - Breaking & Trending Today

Rapport Therapeutics, Inc. Plans $136 Million IPO for June 7th (RAPP) - Vimarsana News

Rapport Therapeutics, Inc. Plans $136 Million IPO for June 7th (RAPP)

Rapport Therapeutics, Inc. (RAPP) expects to raise $136 million in an initial public offering (IPO) on Friday, June 7th, IPO Scoop reports. The company will be issuing 8,000,000 shares at $16.00-$18.00 per share. Rapport Therapeutics, Inc. has a market cap of $601.4 million. Goldman Sachs, Jefferies, TD Cowen and Stifel served as the underwriters for […]

Rapport Therapeutics, Inc. (RAPP) Announces June 7th IPO - Vimarsana News

Rapport Therapeutics, Inc. (RAPP) Announces June 7th IPO

Rapport Therapeutics, Inc. (RAPP) expects to raise $136 million in an IPO on Friday, June 7th, IPO Scoop reports. The company will be issuing 8,000,000 shares at a price of $16.00-$18.00 per share. Rapport Therapeutics, Inc. has a market-cap of $601.4 million. Goldman Sachs, Jefferies, TD Cowen and Stifel served as the underwriters for the […]

Rapport Therapeutics, Inc. (RAPP) to Raise $136 Million in IPO - Vimarsana News

Rapport Therapeutics, Inc. (RAPP) to Raise $136 Million in IPO

Rapport Therapeutics, Inc. (RAPP) is planning to raise $136 million in an IPO on Friday, June 7th, IPO Scoop reports. The company plans to issue 8,000,000 shares at a price of $16.00-$18.00 per share. The company has a market-cap of $601.4 million. Goldman Sachs, Jefferies, TD Cowen and Stifel served as the underwriters for the […]

Intel Corporation: Intel and Apollo Agree to Joint Venture Related to Intel's Fab 34 in Ireland - Vimarsana News

Intel Corporation: Intel and Apollo Agree to Joint Venture Related to Intel's Fab 34 in Ireland

Intel Corporation (Nasdaq: INTC) and Apollo (NYSE: APO) today announced a definitive agreement under which Apollo-managed funds and affiliates will lead an investment of $11 billion to acquire from Intel

EQS-News: QUANTRO Therapeutics GmbH: QUANTRO Therapeutics reaches a milestone in the collaboration with Boehringer Ingelheim to develop first-in-class cancer treatments - Vimarsana News

EQS-News: QUANTRO Therapeutics GmbH: QUANTRO Therapeutics reaches a milestone in the collaboration with Boehringer Ingelheim to develop first-in-class cancer treatments

EQS-News: QUANTRO Therapeutics GmbH / Key word(s): Miscellaneous QUANTRO Therapeutics reaches a milestone in the collaboration with Boehringer Ingelheim to develop first-in-class